The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis

International Journal of Molecular Medicine

Volumn 26, Issue 1, 2010, Pages 3-9

  Yoo, Heon ^a   Sohn, Seil ^a   Nam, Byung Ho ^a   Min, Hye Sook ^a   Jung, Eugene ^a   Shin, Sang Hoon ^a   Gwak, Ho Shin ^a   Lee, Seung Hoon ^a  

^a National Cancer Center   (South Korea)

Author keywords

Carbonic anhydrase 9; Glioma; Hypoxia; Vascular endothelial growth factor

Indexed keywords

CARBONATE DEHYDRATASE IX; PARAFFIN; VASCULOTROPIN;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH; WORLD HEALTH ORGANIZATION;

EID: 77954718379     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000427     Document Type: Article

References (35)

1. Robin ED, Murphy BJ and Theodore J: Coordinate regulation of glycolysis by hypoxia in mammalian cells. J Cell Physiol 118: 287-290, 1984. (Pubitemid 14162998)
2. Haapasalo JA, Nordfors KM, Hilvo M, et al: Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 12: 473-477, 2006.
3. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515, 1996. (Pubitemid 26330463)
4. Brizel DM, Sibley GS, Prosnitz LR, Scher RL and Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285-289, 1997.
5. Nordsmark M, Loncaster J, Aquino-Parsons C, et al: Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol 67: 35-44, 2003.
6. Fyles AW, Milosevic M, Wong R, et al: Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48: 149-156, 1998. (Pubitemid 28423786)
7. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47, 2002.
8. Lal A, Peters H, St Croix B, et al: Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93: 1337-1343, 2001. (Pubitemid 32910575)
9. Olive PL, Aquino-Parsons C, MacPhail SH, et al: Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61: 8924-8929, 2001.
10. Beasley NJ, Wykoff CC, Watson PH, et al: Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 61: 5262-5267, 2001.
11. Wykoff CC, Beasley N, Watson PH, et al: Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158: 1011-1019, 2001.
12. Airley RE, Loncaster J, Raleigh JA, et al: GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 104: 85-91, 2003.
13. Giatromanolaki A, Koukourakis MI, Sivridis E, et al: Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61: 7992-7998, 2001.
14. Chia SK, Wykoff CC, Watson PH, et al: Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19: 3660-3668, 2001.
15. Loncaster JA, Harris AL, Davidson SE, et al: Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61: 6394-6399, 2001.
16. Koukourakis MI, Giatromanolaki A, Sivridis E, et al: Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 7: 3399-3403, 2001.
17. Yoo H, Baia GS, Smith JS, et al: Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res 13: 68-75, 2007. (Pubitemid 46121854)
18. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
19. Saleh M, Stacker SA and Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401, 1996. (Pubitemid 26026370)
20. Shibuya M: Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. FEBS J 276: 4636-4643, 2009.
21. Jacobsen J, Grankvist K, Rasmuson T, Bergh A, Landberg G and Ljungberg B: Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int 93: 297-302, 2004.
22. Linderholm BK, Lindh B, Beckman L, et al: Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. Clin Breast Cancer 4: 340-347, 2003.
23. Uehara M, Sano K, Ikeda H, et al: Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. Oral Oncol 40: 321-325, 2004.
24. Winum JY, Rami M, Scozzafava A, Montero JL and Supuran C: Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med Res Rev 28: 445-463, 2008.
25. Lee S, Shin HJ, Han IO, et al: Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer. Cancer Sci 98: 329-333, 2007.
26. Brennan DJ, Jirstrom K, Kronblad A, et al: CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 12: 6421-6431, 2006.
27. Atkins M, Regan M, McDermott D, et al: Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 11: 3714-3721, 2005.
28. Choi SW, Kim JY, Park JY, Cha IH, Kim J and Lee S: Expression of carbonic anhydrase IX is associated with post-operative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma. Hum Pathol 39: 1317-1322, 2008.
29. Ivanov SV, Kuzmin I, Wei MH, et al: Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 95: 12596-12601, 1998.
30. Korkolopoulou P, Perdiki M, Thymara I, et al: Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum Pathol 38: 629-638, 2007.
31. Preusser M, Wolfsberger S, Haberler C, et al: Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival. Acta Neuropathol 109: 211-216, 2005.
32. Said HM, Hagemann C, Staab A, et al: Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol 83: 398-405, 2007.
33. Zhang Y, Zhang N, Dai B, et al: FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 68: 8733-8742, 2008.
34. Vredenburgh JJ, Desjardins A, Herndon JE II, et al: Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13: 1253-1259, 2007.
35. Zuniga RM, Torcuator R, Jain R, et al: Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan. J Neurooncol 91: 329-336, 2009.